According to new research published in the Annals of Internal Medicine, people who have Type 2 diabetes and are overweight live longer than patients whose body mass index categorizes them as obese, normal or low weight.
Researchers collected all-cause mortality and cardiovascular morbidity information on more than 10,500 patients with Type 2 diabetes (and without known cardiovascular disease), as well as their BMI, for a span of roughly 10 years.
They found overweight or obese patients had a higher rate of cardiac events — including acute coronary syndrome and heart failure — than those of normal weight. However, being overweight was also associated with a lower mortality risk than obese patients and normal-weight patients, whose mortality risks were similar. Additionally, patients with low body weight had the worst prognosis.
The study authors referred to their findings on diabetes-related mortality rates as the “obesity paradox.”
More articles on diabetes:
Sharing diabetes testing supplies leads to hepatitis B outbreak in Pennsylvania
Diabetes, depression increase risk for dementia, study finds
Number of newly identified diabetes cases spike in Medicaid expansion states
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
